Clinical Trial Update: Early Discharge After Mitral and Tricuspid Edge-to-edge Repair: an Assessment of Feasibility and Safety

View source ↗

Summary

A completed clinical trial assessing the feasibility and safety of early discharge after mitral and tricuspid edge-to-edge repair.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Mitral Regurgitation
• Tricuspid Regurgitation

Snippet

Sponsor: Oxford University Hospitals NHS Trust | Conditions: Mitral Regurgitation, Tricuspid Regurgitation | Status: COMPLETED